awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26769850-F8A5BDCB-162E-4FA6-83DB-3182C97BBEAF
Q26769850-F8A5BDCB-162E-4FA6-83DB-3182C97BBEAF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26769850-F8A5BDCB-162E-4FA6-83DB-3182C97BBEAF
Pharmacologic resistance in colorectal cancer: a review
P2860
Q26769850-F8A5BDCB-162E-4FA6-83DB-3182C97BBEAF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26769850-F8A5BDCB-162E-4FA6-83DB-3182C97BBEAF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
363d81bccb44651d44aa2dac391ebed26a8de00a
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.